Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic ...
It is also why I have spent over fifteen years building around a conviction the healthcare industry still resists: when ...
Researchers review how 3D printed hydrogel bioelectronics can improve sensing, adhesion and soft tissue interfaces in medical ...
The Cool Down on MSN
Only a third of Americans like the average vegan product. A US nonprofit thinks AI can fix that
"It’s a valid and important concern, and one we take seriously." ...
A new study asked AI to create a better burger. The result was more than a food-science curiosity: it offered a glimpse into the hidden logic of taste, the limits of optimization, and the stubborn gap ...
The central thesis of this article is that capitalism finds robust support in scientific principles governing complex systems, whereas collectivism lacks comparable empirical or theoretical backing. T ...
The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...
YouTube on MSN
I tried statins - and stopped. Here's why I'm concerned.
When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t just the sensation of pain — it was what that pain might represent.
The Amazing Times on MSN
15 surprising things you own right now that would be totally worthless in a post-apocalyptic world
These 15 items we deem important today would be extremely useless in a post-apocalyptic world, and it goes beyond cash. The ...
Listen to the episode here or wherever you listen to podcasts: Product innovation is always a risky business, with months of ...
AlzeCure licensed NeuroRestore ACD856 to QuantumCell in a deal worth over $2.2B. The real story is not proof, but Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results